Skip to main content
. 2022 Oct 21;34(1):104. doi: 10.1186/s12302-022-00680-6

Table 1.

Summary of the NORMAN-SLE datasets, split by the groups shown in Fig. 4, with suspect list number (S), code, number of entries (lines in the file, in italics) and the accompanying references

Group List number, Code, Entries (total lines) and References

(A)

 > 8000

S0 SUSDAT 109,631 [69, 83]; S71 CECSCREEN 70,397 [84, 85]; S32 REACH2017 68,679 [86]; S17 KEMIMARKET 50,308 [68]; S77 FCCDB 12,285 [8789]; S2 STOFFIDENT 11,289 [17, 90]; S19 MZCLOUD 8742 [91]; S55 ZINC15PHARMA 8646 [9294]

(B)

1700–8000

S33 SOLUTIONSMLOS 6463 [9597]; S27 KWRSJERPS2 5702 [98, 99]; S89 PRORISKPFAS 4777 [100, 101]; S25 OECDPFAS 4725 [6062]; S38 SOLNSLMCTPS 4465 [96, 97, 102]; S49 CPPDBLISTB 3353 [103105]; S13 EUCOSMETICS 3333 [106108]; S70 EISUSGCEIMS 3266 [109]; S73 METXBIODB 3148 [110, 111]; S14 KEMIPFAS 2602 [112, 113]; S21 UATHTARGETS 2466 [114, 115]; S1 MASSBANK 2305 [38, 116, 117]; S75 CYANOMETDB 2124 [118, 119]; S35 INDOORCT16 2056 [6, 120]; S50 CCSCOMPEND 1983 [121123]; S80 PFASGLUEGE 1926 [124, 125]; S22 EPACONS 1705 [126, 127]

(C)

800–1700

S60 SWISSPEST19 1664 [128, 129]; S3 NORMANCT15 1662 [4, 130]; S29 PHYTOTOXINS 1586 [131, 132]; S87 CHLORINETPS 1470 [133, 134]; S31 WRTMSD 1429 [135, 136]; S84 UFZHSFPMT 1310 [137139]; S16 FRENCHLIST 1256 [140]; S37 LITMINEDNEURO 1243 [57, 59]; S53 UFZWANATARG 1235 [141]; S82 EAWAGPMT 1162 [142, 143]; S23 EIUBASURF 1154 [144]; S39 KEMIWWSUS 1123 [145]; S72 NTUPHTW 1068 [146, 147]; S46 PFASNTREV19 1030 [46, 47]; S10 SWISSPHARMA 1020 [13, 148]; S18 TSCASURF 985 [48]; S61 UJICCSLIB 970 [149, 150]; S15 NORMANPRI 967 [151]; S48 CPPDBLISTA 902 [103, 105, 152]; S51 WRIGCHRMS 892 [153]; S76 LUXPHARMA 816 [154, 155]

(D)

300–800

S42 HDXNOEX 765 [156, 157]; S9 PFASTRIER 746 [45]; S6 ITNANTIBIOTIC 676 [158, 159]; S4 UJIBADE 544 [160, 161]; S58 PSYCHOCANNAB 531 [64]; S43 NEUROTOXINS 511 [58, 59]; S66 EAWAGTPS 486 [162, 163]; S34 EXPOSOMEXPL 440 [164166]; S94 FLUOROPEST 423 [167, 168]; S47 ECHAPLASTICS 418 [169, 170]; S7 EAWAGSURF 410 [14, 171]; S78 SLUPESTTPS 400 [172, 173]; S69 LUXPEST 386 [174, 175]; S36 UBAPMT 341 [54, 176, 177]; S8 ATHENSSUS 340 [49, 178]; S92 FLUOROPHARMA 340 [179, 180]; S65 UATHTARGETSGC 334 [181, 182]; S62 NORMANEWS2 321 [183, 184]; S85 MICROCYSTINS 321 [118, 185]; S79 UACCSCEC 311 [186, 187]

(E)

95–300

S57 GREEKPHARMA 263 [188]; S96 ECIPFAS 258 [72]; S11 SWISSPEST 218 [12, 189]; S54 EFSAPRI 212 [190, 191]; S30 PHENANTIOX 209 [192]; S24 HUMANNEUROTOX 190 [56, 59]; S56 UOATARGPHARMA 185 [193195]; S28 EUBIOCIDES 160 [196]; S5 KWRSJERPS 159 [99, 197]; S12 NORMANEWS 156 [198, 199]; S26 MYCOTOXINS 149 [200]; S74 REFTPS 146 [71]; S64 NATOXAQ 130 [201, 202]; S91 CECTOYS 126 [203, 204]; S68 HSDBTPS 101 [174, 205]; S86 TATTOOINK 98 [206208]; S41 CCL4 96 [209, 210]; S83 CCL5 96 [211, 212]; S52 THSMOKE 95 [213]

(F)

 < 95

S95 PFASANEXCH 94 [214, 215]; S63 UBADWGW 84 [176, 216]; S59 NPINSECT 83 [217]; S67 TBUTYLPHENOLS 77 [218]; S97 UBABPAALT 71 [219, 220]; S88 UBABIOCIDES 62 [221223]; S93 CECMOUTHING 60 [203, 204]; S40 ALGALTOX 54 [224]; S20 BISPHENOLS 52 [225, 226]; S81 THSTPS 52 [227]; S45 SYNTHCANNAB 39 [63]; S90 ZEROPMBOX1 38 [228, 229]; S44 STATINS 18 [230]; S98 TIRECHEM 16 [231]

Full details given in Additional file 1 and Additional file 2 [81, 82]